Updated
Updated · KUTV 2News · Jul 24
Morgan Hill Receives $3.5 Million Niemann-Pick Treatment, Flying to Chicago Every 2 Weeks
Updated
Updated · KUTV 2News · Jul 24

Morgan Hill Receives $3.5 Million Niemann-Pick Treatment, Flying to Chicago Every 2 Weeks

1 articles · Updated · KUTV 2News · Jul 24

Summary

  • $3.5 million in annual drugs is helping 21-year-old Morgan Hill manage Niemann-Pick disease, a rare fatal disorder her family says may make her the only diagnosed patient in Utah.
  • Biweekly trips from Utah to Chicago let Hill receive infusions of a new drug at a hospital specializing in Niemann-Pick, and her parents said the treatment has boosted her energy and helped her eat on her own.
  • The disease disrupts how cells process fats and cholesterol, and Hill describes its effects as resembling Alzheimer's, dementia and Parkinson's.
  • Her family says Niemann-Pick is often misdiagnosed and argues earlier intervention can slow progression even though there is still no cure.

Insights

Why must a Utah woman fly to Chicago every two weeks for Niemann-Pick treatment, and what does that reveal about rare-disease care access?
How can one rare-disease patient’s therapy cost over $3.5 million a year, yet still leave unanswered questions about long-term outcomes?
Could Utah be missing more Niemann-Pick cases, and what signs should families and doctors catch before years are lost to misdiagnosis?